Citation Impact
Citing Papers
Advanced Atherosclerotic Foam Cell Formation Has Features of an Acquired Lysosomal Storage Disorder
2006
Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects
2001
Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects
1998
Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells
2005
Identification of the Interaction Site within Acyl-CoA:Cholesterol Acyltransferase 2 for the Isoform-specific Inhibitor Pyripyropene A
2008 StandoutNobel
Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells
1999
SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome
2004
Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
2012
Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin:cholesterol acyltransferase
2001
Use of cyclodextrins for manipulating cellular cholesterol content
1997
Tangier disease as a test of the reverse cholesterol transport hypothesis
2000
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
1998 StandoutNature
Atheroprotective mechanisms of HDL
1999
Calcification of the Aortic Arch
2000 Standout
Probing Red Cell Membrane Cholesterol Movement with Cyclodextrin
2002
Role of cholesterol in the function and organization of G-protein coupled receptors
2006
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
2007
Scavenger Receptor Class B Type I-mediated Cholesteryl Ester-selective Uptake and Efflux of Unesterified Cholesterol
2004
Multi-protein assemblies underlie the mesoscale organization of the plasma membrane
2014 StandoutNobel
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1
2000
Apolipoprotein A-IMilano: current perspectives
2003
Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: Relation to age and risk factors
1994
Trans Polyunsaturated Fatty Acids Have More Adverse Effects than Saturated Fatty Acids on the Concentration and Composition of Lipoproteins Secreted by Human Hepatoma HepG2 Cells
2002
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis
2003
Tangier disease and ABCA1
2000
Cellular Cholesterol Efflux Mediated by Cyclodextrins
1995 Standout
Future Therapeutic Directions in Reverse Cholesterol Transport
2010
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X Receptor
2000
Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species
2004
Nanoporous Carbohydrate Metal–Organic Frameworks
2011 StandoutNobel
High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI
2000
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
1998 StandoutNature
Exclusive expression of transmembrane TNF-α in mice reduces the inflammatory response in early lipid lesions of aortic sinus
2003
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre β-HDL, phospholipid transfer protein and cholesterol esterification
2007
Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix
1999
High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C
1999
Periodontitis decreases the antiatherogenic potency of high density lipoprotein
2004
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice
2000
Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients
1996
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Beyond High-Density Lipoprotein Cholesterol Levels
2008
Effect of shell-crosslinking of micelles on endocytosis and exocytosis: acceleration of exocytosis by crosslinking
2012
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
The Cholesterol Mobilizing Transporter ABCA1 as a New Therapeutic Target for Cardiovascular Disease
2002
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein
1996
Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
2008
High-Density Lipoprotein from Hypercholesterolemic Animals Has Peroxidized Lipids and Oligomeric Apolipoprotein A-I: Its Putative Role in Atherogenesis
1997
Cholesterol, a Cell Size-dependent Signal That Regulates Glucose Metabolism and Gene Expression in Adipocytes
2001
Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies
2007
Membrane lipids: where they are and how they behave
2008 Standout
Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL
2004
Structural modifications of HDL and functional consequences
2005
Atherosclerosis — An Inflammatory Disease
1999 Standout
Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains
2009
Increased atherosclerosis in LDL receptor–null mice lacking ACAT1 in macrophages
2001
Hepatitis C Virus Entry
2007 StandoutNobel
Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels
2000
Quantity of Coronary Artery Calcium Detected by Electron Beam Computed Tomography in Asymptomatic Subjects and Angiographically Studied Patients
1995
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination
2012
Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
2003
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
2000
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
2004
Serum Amyloid A Promotes Cholesterol Efflux Mediated by Scavenger Receptor B-I
2005
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
1997
Atherosclerosis
2000 StandoutNature
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
2004 StandoutNobel
Progression of Coronary Artery Calcification: A Pilot Study
1999
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Hepatitis C Virus NS5A Colocalizes with the Core Protein on Lipid Droplets and Interacts with Apolipoproteins
2002
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
HDL therapy for the acute treatment of atherosclerosis
2002
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Atherosclerosis
2001 Standout
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
2006 Standout
Human neutrophils employ the myeloperoxidase/hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A‐I
2001
High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase
1997
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
1999
Cholesterol Efflux CapacityIn VitroPredicts the Severity and Extent of Coronary Artery Disease in Patients with and without Type 2 Diabetes
2001
Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models
1999
Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II
2002
The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues
2003
High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection
2001
High-Dose Recombinant Apolipoprotein A-I Milano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E–Deficient Mice
2001
A Single Amino Acid Deletion in the Carboxy Terminal of Apolipoprotein A-I Impairs Lipid Binding and Cellular Interaction
2000
Air Pollution and Cardiovascular Disease
2004 Standout
High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
2000
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Cooperative capture synthesis: yet another playground for copper-free click chemistry
2016 StandoutNobel
Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor
2012 StandoutNobel
Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo
2005
Cardiolipin is a normal component of human plasma lipoproteins
2000
Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein
2004
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
Review: A History of Cyclodextrins
2014 Standout
Ability of Serum to Decrease Cellular AcylCoA:Cholesterol Acyl Transferase Activity Predicts Cardiovascular Outcomes
2005
Macrophage Reverse Cholesterol Transport
2006
Difluorobenzocyclooctyne: Synthesis, Reactivity, and Stabilization by β-Cyclodextrin
2010 StandoutNobel
Vitamin E: function and metabolism
1999
Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography
2000
Electron-Beam Computed Tomography, Coronary Artery Calcium, and Evaluation of Patients with Coronary Artery Disease
1998
Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IV
1996 Science
Sphingomyelin Hydrolysis to Ceramide during the Execution Phase of Apoptosis Results from Phospholipid Scrambling and Alters Cell-Surface Morphology
2000
Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver
1996
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Critical Analysis of Coronary Artery Bypass Graft Surgery: A 30-Year Journey
1998
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Effects of Recombinant Apolipoprotein A-I Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice
1998
Small high density lipoprotein subclasses: some of their physico-chemical properties and stability in solution.
2005
Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW Cells
2002
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Extracoronary Atherosclerotic Plaque at Multiple Sites and Total Coronary Calcification Deposit in Asymptomatic Men
1995
Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits
1996
THE HEALTH BENEFITS OF WINE
2000
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport
2004
Different Effects of Subclasses of HDL Containing ApoA-I but Not ApoA-II (LpA-I) on Cholesterol Esterification in Plasma and Net Cholesterol Efflux From Foam Cells
1995
High Density Lipoproteins and Arteriosclerosis
2001
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
2005
Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface
1999
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E–Deficient Mice
2001
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
1999 George Lyman Duff Memorial Lecture
2000
Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors
1995
Increased Cholesterol Efflux Potential of Sera From ApoA-I Milano Carriers and Transgenic Mice
1999
PanR1, a Dominant Negative Missense Allele of the Gene Encoding TNF-α (Tnf), Does Not Impair Lymphoid Development
2006 StandoutNobel
Cholesterol Sensing, Trafficking, and Esterification
2006
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Works of V. Atger being referenced
Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.
1996
Cell cholesterol efflux: integration of old and new observations provides new insights
1999
Overexpression of Human Apolipoprotein A-II in Mice Induces Hypertriglyceridemia Due to Defective Very Low Density Lipoprotein Hydrolysis
1999
Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
1995
Oxidative modification of high‐density lipoprotein 3 induced by human polymorphonuclear neutrophils
1999
Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity
1996
Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.
1997
Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men
1998
Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system
2001
Structural changes of high‐density‐lipoprotein apolipoproteins following incubation with human polymorphonuclear cells
1994
Influence of end-stage renal failure on concentrations of free apolipoprotein A-1 in serum.
1989
Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic men. The PCV METRA Group.
1992
Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group.
1992
High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells
1996
Opposite Effects of Plasma From Human Apolipoprotein A-II Transgenic Mice on Cholesterol Efflux From J774 Macrophages and Fu5AH Hepatoma Cells
2002
Apolipoprotein A-II/A-I Ratio Is a Key Determinant in Vivo of HDL Concentration and Formation of Pre-β HDL Containing Apolipoprotein A-II
2001
HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum
1997
A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.
1994
Human ApoA-IV Overexpression in Transgenic Mice Induces cAMP-Stimulated Cholesterol Efflux From J774 Macrophages to Whole Serum
2000
Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome: importance of the HDL-phospholipids/free cholesterol ratio and of the HDL size distribution
1999
Structural and Functional Comparison of HDL From Homologous Human Plasma and Follicular Fluid
1997